Research Proposal

Biosciences Online Communities

Goals

To provide a list of five bioscience online communities developed for industry development similar to adMare Academy Community (https://admarebiocommunity.com/). For each, we will provide the name, a website link, the objective, the number of members, date of establishment, and impact data.

Early Findings

A list of three biosciences online communities developed for industry development includes BioCT, Fitzsimons Innovation Community, and the Swiss Biotech Association communities.

BioCT

  • A website link to BioCT is provided herein.
  • BioCT is dedicated to “growing the vibrant bioscience ecosystem in Connecticut by supporting innovation, collaboration, networking, education, talent engagement, and advocacy.”
  • It brings together companies, entrepreneurs, investors, institutions, government, service providers, and other passionate, dedicated people to create a thriving community to improve patients’ lives and public health and drive economic growth.

Fitzsimons Innovation Community

  • A website link to the Fitzsimons Innovation Community is provided herein.
  • The community was established in the 1990s when the US Army decommissioned the hospital and base in Colorado.
  • Fitzsimons claims to be a leading Innovation Community that is boldly transforming the future of health and care.
  • It offers office spaces and specialized life sciences labs with the chance to work with researchers and clinicians at a world-class medical destination.

Swiss Biotech Association

  • A website link to the Swiss Biotech Association community is provided herein.
  • It was founded in 1998.
  • The Swiss Biotech Association developed its community for employees of member companies. The community "enables direct exchange between members, features a news section, provides files and information, shows discount codes for events, and enables discussions within specific platform topics."
  • The association has about six bio-related communities, including industrial biotechnology, antimicrobial resistance, clinical development and regulatory issues, therapeutic biologics, stem cells and advanced therapies, and rare diseases and orphan medicinal products.
Prepared By
Blessing S.
610 assignments | 5.0